GlassScriptPhysician profile
Sally Twedt
NPI 1972578722
$673.65
in general payments reported to CMS, 2019-2025
11 companies · $115 in 2025
The $115 reported for 2025 was more than what a typical Pediatrics (Nurse Practitioner) provider received nationally (typical 2025 total: $93.49).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $40.14 · 2022: $290 · 2023: $88.25 · 2024: $141 · 2025: $115.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $344.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $343.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supernus Pharmaceuticals, INC. | $179.14 | 2021-2024 | Qelbree, Qelbree |
| Ironshore Pharmaceuticals INC. | $86.99 | 2021-2024 | Jornay Pm |
| Corium, LLC | $83.83 | 2022-2023 | Azstarys |
| Merck Sharp & Dohme LLC | $72.36 | 2022-2025 | Vaxneuvance, M-M-R II, Vaxelis |
| Seqirus USA INC | $50.61 | 2022-2025 | Flucelvax |
| Pfizer INC. | $47.92 | 2022-2023 | |
| Sanofi Pasteur INC. | $47.74 | 2022 | |
| Kaleo, INC. | $42.71 | 2022 | |
| Collegium Pharmaceutical, INC. | $33.68 | 2025 | Jornay Pm |
| Cranial Technologies, INC | $14.63 | 2025 | Doc Band |
| Sanofi-Aventis U.S. LLC | $14.04 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sally Twedt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.